Table 1 Participant characteristics

From: Resting-state global brain activity affects early β-amyloid accumulation in default mode network

 

Stage 1 (S1)

Stage 2 (S2)

Stage 3 (S3)

P-value

N = 144

CSF-/PET- (N = 50)

CSF+/PET- (N = 23)

CSF+/PET+(N = 71)

S2 vs S1

S3 vs S1

S3 vs S2

Age

71.7 (8.0)

70.5 (7.3)

73.9 (7.0)

0.54

0.12

0.051

Gender (M/F)

22/28

16/7

33/38

0.049

0.85

0.060

Group (AD:MCI:SMC:Control)

2:23:12:13

0:12:3:8

21:37:6:7

APOE4# (0:1:2)

42:8:0

15:5:3

19:38:14

  1. Data represent the mean and standard deviation (in parentheses) unless otherwise indicated. Pairwise comparisons were performed based on the two-sample t test (two-sided) for all measures except for gender where a Fisher exact test was used (significant result is highlighted with bold formatting).
  2. M/F male/female, AD Alzheimer’s disease group, MCI mild cognitive impairment, SMC significant memory concern, APOE4# the number of APOE ε4 carrying, CSF+ <192 ng/L, PET+  cortical Aβ > 0.872 SUVR.